{
    "2019-02-12": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Dosing",
                        "Phase I",
                        "Melanoma",
                        "ADU-S100",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}